Micromanagement of drug-resistant advanced gastrointestinal stromal tumors: regorafenib—new ammunition in battling exon 17 mutations

類似資料

• Response letter on Micromanagement of drug-resistant advanced gastrointestinal stromal tumors: regorafenib—new ammunition in battling exon 17 mutations
  著者:: Yeh, Chun-Nan
  出版事項: (2018)
• A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17
  著者:: Yeh, Chun-Nan, 等
  出版事項: (2017)
• Clinical activity of regorafenib in PDGFRA-mutated gastrointestinal stromal tumor
  著者:: Grellety, Thomas, 等
  出版事項: (2015)
• Targeting gastrointestinal stromal tumors: the role of regorafenib
  著者:: Schroeder, Brett, 等
  出版事項: (2016)
• Is exon mutation analysis needed for adjuvant treatment of gastrointestinal stromal tumor?
  著者:: Şendur, Mehmet Ali Nahit, 等
  出版事項: (2013)